CryoPort Inc (NASDAQ:CYRX) has earned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $19.75.
Several equities research analysts have recently issued reports on the stock. BidaskClub raised shares of CryoPort from a “hold” rating to a “buy” rating in a research report on Thursday, February 7th. ValuEngine raised shares of CryoPort from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 31st.
In other news, Director Richard J. Berman sold 30,000 shares of the stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $10.06, for a total value of $301,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 9.60% of the stock is owned by corporate insiders.
CryoPort stock opened at $11.12 on Tuesday. CryoPort has a 52-week low of $6.66 and a 52-week high of $16.88. The firm has a market capitalization of $340.77 million, a PE ratio of -32.71 and a beta of 1.22.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
See Also: Hedge Funds
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.